Frequency and clinical features of treatment-refractory myasthenia gravis

ConclusionA small subgroup of patients with generalized myasthenia gravis do not respond sufficiently to standard therapies. Refractory disease has considerable implications for both patients and health care providers and highlights an unmet need for new treatment options.
Source: Journal of Neurology - Category: Neurology Source Type: research